SEC Filings | Constellation Pharmaceuticals

SEC Filings

Filing date	Form	Description	Filing Group	View
Jan 26, 2021	5	Annual filing director officer or owner of more than ten percent.	3,4,5	0000899243-21-003337.pdf 0000899243-21-003337.rtf 0000899243-21-003337.xls View HTML
Jan 20, 2021	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-21-000392.pdf 0001562180-21-000392.rtf 0001562180-21-000392.xls View HTML
Dec 28, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-007466.pdf 0001562180-20-007466.rtf 0001562180-20-007466.xls View HTML
Dec 22, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0001562180-20-007432.pdf 0001562180-20-007432.rtf 0001562180-20-007432.xls View HTML
Dec 16, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-20-034164.pdf 0000899243-20-034164.rtf 0000899243-20-034164.xls View HTML
Dec 16, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-20-034165.pdf 0000899243-20-034165.rtf 0000899243-20-034165.xls View HTML
Dec 07, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001564590-20-056302.pdf 0001564590-20-056302.rtf 0001564590-20-056302.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 18, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001564590-20-054498.pdf 0001564590-20-054498.rtf 0001564590-20-054498.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 09, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	0001564590-20-052513.pdf 0001564590-20-052513.rtf 0001564590-20-052513.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Oct 29, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001564590-20-048495.pdf 0001564590-20-048495.rtf 0001564590-20-048495.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.